Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Carasent AB (publ)LTS:0H9M 80 OCF Margin % is 25.96% as of Jun. 2026, which is 89% above its 10-year median of 13.71. GuruFocus rates LTS:0H9M with a GF Score™ of 80/100 and a GF Value™ of kr24.22. The stock has 3 warning signs investors should review. Among 667 Healthcare Providers & Services companies, Carasent AB (publ) ranks better than 90.25% on this metric.
The historical rank and industry rank for Carasent AB (publ)'s OCF Margin % or its related term are showing as below:
LTS:0H9M'
s OCF Margin % Range Over the Past 10 Years
Min: -18.37 Med: 13.71 Max: 26.58
Current: 24.94
During the past 13 years, the highest OCF Margin % of Carasent AB (publ) was 26.58%. The lowest was -18.37%. And the median was 13.71%.
LTS:0H9M's OCF Margin % is ranked better than 90.25% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 8.29
vs LTS:0H9M: 24.94
Carasent AB (publ) OCF Margin % Related Terms
Carasent AB (publ) OCF Margin % Historical Data
* Premium members only.
The historical data trend for Carasent AB (publ)'s OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0H9M vs VEEV, BTSG, TEM: OCF Margin % Comparison
For the Health Information Services subindustry, Carasent AB (publ)'s OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carasent AB (publ) OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Carasent AB (publ)'s OCF Margin % distribution charts can be found below:
* The bar in red indicates where Carasent AB (publ)'s OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carasent AB (publ) (LTS:0H9M) has a OCF Margin % of 25.96% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Carasent AB (publ) and its competitors. This is 89% above median its historical median of 13.71. According to the industry distribution chart, Carasent AB (publ) ranks #65 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 9.7%.
Is Carasent AB (publ)'s OCF Margin % too high?
Carasent AB (publ)'s current OCF Margin % of 25.96% is 89% above median its 10-year median of 13.71. The Healthcare Providers & Services industry median OCF Margin % is 8.29. Carasent AB (publ)'s value of 25.96% is 213.1% above this industry median. Based on the distribution chart, Carasent AB (publ) ranks #65 out of 667 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Carasent AB (publ) has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Carasent AB (publ)'s OCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Carasent AB (publ) ranks #65 out of 667 companies for OCF Margin %. This places Carasent AB (publ) in the top 10% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 8.29. Carasent AB (publ)'s value of 25.96% is 213.1% above this benchmark. While the company's 10-year median is 13.71 vs. the industry median of 8.29, Carasent AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.29, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carasent AB (publ)'s current OCF Margin % of 25.96% is 213.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Carasent AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carasent AB (publ)'s current OCF Margin % is 25.96%, which is 89% above median its own 10-year median of 13.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carasent AB (publ) stock overvalued right now?
Carasent AB (publ) (LTS:0H9M) has a current OCF Margin % of 25.96%. The stock's GF Value™ is kr24.22, compared to a current price of kr20.60 — trading 14.9% below its estimated fair value. The current OCF Margin % is 25.96%, which is 89% above median its 10-year median of 13.71 and 213.1% above the Healthcare Providers & Services industry median of 8.29. Carasent AB (publ)'s overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Carasent AB (publ) (LTS:0H9M), the current OCF Margin % is 25.96% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carasent AB (publ) (LTS:0H9M) Overvalued in 2026?
Based on GuruFocus' analysis, Carasent AB (publ) stock appears to be undervalued.
The current stock price of kr20.60 is trading 14.9% below its estimated GF Value™ of kr24.22.
Key valuation signals for LTS:0H9M:
OCF Margin %: 25.96% (89% above median its 10-year median of 13.71)
GF Value™: kr24.22 vs. price of kr20.60 (14.9% below fair value)
Industry Position: 213.1% above the Healthcare Providers & Services median (#65 of 667)
No single metric tells the full story. See the LTS:0H9M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.
80GF Score
Get the complete analysis for LTS:0H9M
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0H9M has been successfully added to your 
